Curiox BioSystems Co

Curiox BioSystems Co Debt/Market Cap

The Debt to Market Capitalization Ratio of Curiox BioSystems Co (445680.KQ) as of Oct 29, 2026 is 0.04 %. In the previous year, Debt to Market Capitalization Ratio was 0.02 % — a change of 149.26% (higher).

Debt/Market Cap

0.04 %

YoY

149.26%

Last updated:

Debt to Market Capitalization Ratio of Curiox BioSystems Co is 2023 0.04 % . Debt to Market Capitalization Ratio of Curiox BioSystems Co was 2022 0.02 % . It decreases by 149.26% higher compared to the previous year.

The Curiox BioSystems Co Debt/Market Cap history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt/Market Cap
Date
Debt/Market Cap
Jan 1, 2021
0.69 KRW
Jan 1, 2022
0.02 KRW
Jan 1, 2023
0.04 KRW
The Curiox BioSystems Co Debt/Market Cap history
YEARDebt/Market CapYoY
0.04 %+149.26%
0.02 %-97.64%
0.69 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Curiox BioSystems Co Stock analysis

What does Curiox BioSystems Co do? Curiox BioSystems Co Ltd generates revenue through the manufacture and sale of automation equipment and consumables for cell analysis processes. The company offers cell pretreatment automation devices, washing machines, and plates, alongside high-capacity adapters, strip spacers, and buffer exchanger products. These products are sold to customers in the Life Sciences Tools & Services industry, primarily within the Korean market. The firm's focus on automation solutions for cell analysis drives its product portfolio and customer base. The company's product lines include cell pretreatment automation devices, washing machines, plates, high-capacity adapters, strip spacers, and buffer exchanger products. These items are designed for use in cell analysis processes, targeting clients who require efficient and precise laboratory equipment. The sales of these specialized tools form the core of Curiox BioSystems' revenue streams. Curiox BioSystems operates within the Life Sciences Tools & Services industry, focusing on providing automation solutions for cell analysis. Its products are manufactured and sold directly to end-users in the life sciences sector, including research institutions and laboratories. The company's revenue is derived from the direct sale of its equipment and consumables without intermediaries. Curiox BioSystems Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Curiox BioSystems Co stock

Debt to Market Capitalization Ratio of Curiox BioSystems Co is 0.04 % in 2023.

Debt to Market Capitalization Ratio of Curiox BioSystems Co changed from 0.02 % to 0.04 %, representing a 149.26% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Debt to Market Capitalization Ratio Curiox BioSystems Co since 2006 – with annual values, charts, and detailed analysis.

Debt/Market Cap compares total debt to the market value of equity. It provides a market-based view of financial leverage.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Debt to Market Capitalization Ratio's Curiox BioSystems Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Leverage — Curiox BioSystems Co

Debt-to-EquityNet Debt / EBITDAInterest CoverageCurrent RatioQuick RatioCash RatioDebt / AssetsFinancial LeverageEquity RatioLT Debt/EquityNet Debt/EquityDebt/EBITDADSCRFinancial Debt RatioOCF/DebtFCF/DebtNet Debt/FCFDebt/Market Cap

All Key Metrics — Curiox BioSystems Co